A rise in reported health issues linked to various Rhino-branded male enhancement supplements has prompted the Food and Drug Administration (FDA) to issue a warning to consumers that the products should not be purchased or used because they contain hidden drugs that can be dangerous to consumers’ health.
The FDA has received reports of people experiencing chest pain, severe headaches and prolonged erections after taking a Rhino product that led to surgical intervention and hospitalization due to extreme drops in blood pressure.
Since 2007, the FDA has identified more than 25 products marketed with variations of the name “Rhino” that contain hidden drugs. Despite FDA warnings, the supplements continue to be sold at gas stations and convenience stores, as well as on websites like eBay and Amazon. More recently, these unapproved products have been discovered in international mail shipments to the United States. They are often sold in single-serving package sizes and include names such as Platinum Rhino 2500, Krazzy Rhino 25000 and Gold Rhino 25000.
“Since 2015, the FDA’s Office of Criminal Investigations has been investigating a South Korean national living in the Los Angeles area for smuggling raw materials, producing Rhino capsules and distributing the misbranded drugs throughout the U.S.,” the FDA said in a News Release. “The case led to an indictment, which is being prosecuted by the U.S. Department of Justice. The FDA continues to pursue regulatory and criminal actions against those who violate federal law.”
These Rhino products have been found to contain undeclared drug ingredients that are the same as or structurally similar to the active ingredients in FDA-approved prescription drugs to treat erectile dysfunction, such as Viagra and Cialis. These medications can be dangerous, especially for people who take nitrates, and can significantly lower blood pressure. People with diabetes, high blood pressure, high cholesterol or heart disease often take nitrates.
Consumers who have experienced adverse health effects that may be related to any dietary supplement should seek medical attention as needed and report the issue to the FDA MedWatch Safety Information program at www.FDA.gov/MedWatch/Report.htm.
Source: FDA News Release